Par Drugs (India) Market Value
| PAR Stock | 106.20 5.05 4.99% |
| Symbol | Par |
Par Drugs 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Par Drugs' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Par Drugs.
| 04/20/2025 |
| 07/19/2025 |
If you would invest 0.00 in Par Drugs on April 20, 2025 and sell it all today you would earn a total of 0.00 from holding Par Drugs And or generate 0.0% return on investment in Par Drugs over 90 days. Par Drugs is related to or competes with GVP Infotech, Kingfa Science, Rico Auto, GACM Technologies, Tribhovandas Bhimji, Parag Milk, and Heubach Colorants. Par Drugs is entity of India. It is traded as Stock on NSE exchange. More
Par Drugs Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Par Drugs' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Par Drugs And upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 1.5 | |||
| Information Ratio | (0.01) | |||
| Maximum Drawdown | 8.43 | |||
| Value At Risk | (2.31) | |||
| Potential Upside | 2.94 |
Par Drugs Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Par Drugs' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Par Drugs' standard deviation. In reality, there are many statistical measures that can use Par Drugs historical prices to predict the future Par Drugs' volatility.| Risk Adjusted Performance | 0.0706 | |||
| Jensen Alpha | 0.1248 | |||
| Total Risk Alpha | (0.13) | |||
| Sortino Ratio | (0.01) | |||
| Treynor Ratio | (1.06) |
Par Drugs And Backtested Returns
At this point, Par Drugs is very steady. Par Drugs And maintains Sharpe Ratio (i.e., Efficiency) of 0.0303, which implies the firm had a 0.0303 % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Par Drugs And, which you can use to evaluate the volatility of the company. Please check Par Drugs' Semi Deviation of 1.4, risk adjusted performance of 0.0706, and Coefficient Of Variation of 1413.45 to confirm if the risk estimate we provide is consistent with the expected return of 0.0509%. Par Drugs has a performance score of 2 on a scale of 0 to 100. The company holds a Beta of -0.1, which implies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Par Drugs are expected to decrease at a much lower rate. During the bear market, Par Drugs is likely to outperform the market. Par Drugs And right now holds a risk of 1.68%. Please check Par Drugs And skewness, day typical price, and the relationship between the downside variance and daily balance of power , to decide if Par Drugs And will be following its historical price patterns.
Auto-correlation | 0.08 |
Virtually no predictability
Par Drugs And has virtually no predictability. Overlapping area represents the amount of predictability between Par Drugs time series from 20th of April 2025 to 4th of June 2025 and 4th of June 2025 to 19th of July 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Par Drugs And price movement. The serial correlation of 0.08 indicates that barely 8.0% of current Par Drugs price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.08 | |
| Spearman Rank Test | 0.1 | |
| Residual Average | 0.0 | |
| Price Variance | 3.43 |
Par Drugs And lagged returns against current returns
Autocorrelation, which is Par Drugs stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Par Drugs' stock expected returns. We can calculate the autocorrelation of Par Drugs returns to help us make a trade decision. For example, suppose you find that Par Drugs has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Par Drugs regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Par Drugs stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Par Drugs stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Par Drugs stock over time.
Current vs Lagged Prices |
| Timeline |
Par Drugs Lagged Returns
When evaluating Par Drugs' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Par Drugs stock have on its future price. Par Drugs autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Par Drugs autocorrelation shows the relationship between Par Drugs stock current value and its past values and can show if there is a momentum factor associated with investing in Par Drugs And.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Par Stock
Par Drugs financial ratios help investors to determine whether Par Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Par with respect to the benefits of owning Par Drugs security.